Hirai, F., Edagawa, M., Shimamatsu, S., Toyozawa, R., Toyokawa, G., Nosaki, K., . . . Ichinose, Y. (2017). Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type. Oncol Lett.
استشهاد بنمط شيكاغوHirai, Fumihiko, et al. "Evaluation of Erlotinib for the Treatment of Patients With Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Wild Type." Oncol Lett 2017.
MLA استشهادHirai, Fumihiko, et al. "Evaluation of Erlotinib for the Treatment of Patients With Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Wild Type." Oncol Lett 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.